Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection-Reference-Cited by-同舟云学术

Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection

Published:2014-12 Issue:1 Volume:11 Page:
ISSN:1742-2094
Container-title:Journal of Neuroinflammation
language:en
Short-container-title:J Neuroinflammation

Author:

Suh Joome,Sinclair Elizabeth,Peterson Julia,Lee Evelyn,Kyriakides Tassos C,Li Fang-yong,Hagberg Lars,Fuchs Dietmar,Price Richard W,Gisslen Magnus,Spudich Serena

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology,Immunology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1186/s12974-014-0199-y.pdf

Reference39 articles.

1. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I: HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study. Neurology. 2010, 75: 2087-2096. 10.1212/WNL.0b013e318200d727.

2. Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, Thrasher D, Goetz MB, Stefaniak M: Medication adherence among HIV + adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002, 59: 1944-1950. 10.1212/01.WNL.0000038347.48137.67.

3. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I: The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004, 10: 317-331. 10.1017/S1355617704102130.

4. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I: Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol. 1997, 54: 416-424. 10.1001/archneur.1997.00550160054016.

5. Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P: Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr. 2007, 45: 174-182. 10.1097/QAI.0b013e318042e1ee.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central Nervous System Effects of Early HIV Infection and Consequences of Antiretroviral Therapy Initiation during Acute HIV;Viruses;2024-07-05

2. A Canadian Survey of Research on HIV-1 Latency—Where Are We Now and Where Are We Heading?;Viruses;2024-02-01

3. Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management;Nature Reviews Neurology;2023-10-10

4. Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV;Viruses;2023-08-30

5. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat;Viral Infections and Antiviral Therapies;2023